Brett Monia, Ionis CEO
Novartis, Ionis will work together again in the next-generation cardio space
Novartis is once again teaming up with Ionis on a next-generation siRNA cardio drug, picking up another shot in an increasingly competitive space.
The deal …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.